Pharma Asia | BusinessCopyright 2007 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.India’s Bal Pharma Limited has announced their expansion plans in the Andhra Pradesh market to garner control over a market in which they already have a substantial presence and market share. The company ...http://www.pharmaasia.com/article-7115-balpharmaexpandsinandhrapradesh-Asia.htmlIndia’s Ankur Drugs and Pharma Ltd has posted substantial turnover for the first quarter of the 2009 fiscal. Net Income rose 70.23% to Rs. 231.14 crore, up from Rs. 135.78 crores in the last fiscal. ...http://www.pharmaasia.com/article-7114-ankurdrugsq1turnoverup7023-Asia.htmlMetformin producer Wanbury Ltd has posted its fifth quarter unaudited financial results, as the financial year-end of the company has been extended till September 30, 2008. The company’s total income ...http://www.pharmaasia.com/article-7111-wanburyq1totalincomeup36-Asia.htmlBayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. say the State Food and Drug Administration (SFDA) of China has approved Nexavar (sorafenib) tablets for the treatment of patients with unresectable ...http://www.pharmaasia.com/article-7107-nexavarapprovedforlivercancerinchina-Asia.htmlESA Biosciences has named James P Whelan as vice president of sales and marketing for the clinical-diagnostics business. He comes to ESA from Laboratory Corporation of America, where he was vice president ...http://www.pharmaasia.com/article-7103-newesasalesandmarketingvp-Asia.htmlChina’s plastic packaging solutions and plastic bottle production equipment company China Bottles Inc says its June contracts amounted to about $3.3 million. This figure represents a three fold increase ...http://www.pharmaasia.com/article-7101-chinabottleswins33mincontracts-Asia.htmlNovartis has announced a flexible long-term partnership with Lonza to rapidly scale up technical development and clinical production for part of the rapidly growing Novartis biologics pipeline. Under ...http://www.pharmaasia.com/article-7089-companiestogrowbiologicspipeline-Asia.htmlAdvanced Chemistry Development, Inc., (ACD/Labs) is offering a 30-day free trial of ACD/MS Fragmenter—a useful tool for predicting MS fragmentation of small organic molecules. ACD/MS Fragmenter helps ...http://www.pharmaasia.com/article-7086-freemssoftwaretrial-Asia.htmlPatheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, has completed a shareholders agreement and a sales and marketing agreement with ...http://www.pharmaasia.com/article-7080-patheonwillpromotebspscytotoxics-Asia.htmlDaiichi Sankyo Company, Limited, and Eli Lilly and Company said that the US Food and Drug Administration (FDA) has extended the review period for the prasugrel new drug application (NDA) based on supplemental ...http://www.pharmaasia.com/article-7079-fdaextendsreviewperiodfordaiichisankyolillyinvestigativedrug-Asia.html